OPEN ACCESS pISSN 2234-3806
eISSN 2234-3814

Table. 2.

Table. 2.

Policies for transfusion in ABO-incompatible solid organ transplantation among the 34 respondents

Variable N (%)
Choice of ABO group for blood component transfusion in major ABOi SOT
RBC
Recipient’s group 24 (70.6)
Group O 10 (29.4)
Platelets
Group AB 17 (50.0)
Donor’s group 13 (38.2)
Group AB or donor’s group 2 (5.9)
Recipient’s group 2 (5.9)
Plasma
Group AB 19 (55.9)
Donor’s group 11 (32.4)
Group AB or donor’s group 3 (8.8)
Recipient’s group except for plasmapheresis in which group AB plasma was transfused 1 (2.9)
Choice of ABO group for blood component transfusion in bidirectional ABOi SOT
RBC
Recipient’s group 19 (55.9)
Group O 15 (44.1)
Platelets
Group AB 32 (94.1)
Recipient’s group 2 (5.9)
Plasma
Group AB 33 (97.1)
Recipient’s group except for plasmapheresis in which group AB plasma was transfused 1 (2.9)
Duration of ABO non-identical transfusion after ABOi SOT
Permanent 20 (58.9)
Six months 1 (2.9)
Four weeks 4 (11.8)
Three weeks 1 (2.9)
Two weeks 3 (8.8)
Depending on the patients’ condition 3 (8.8)
No criteria 1 (2.9)
No incompatible transfusion except for plasmapheresis 1 (2.9)
Personnel who determine the ABO group of blood components
Specialist in transfusion medicine 24 (70.6)
Physician 5 (14.7)
Both by consultation 5 (14.7)
Process for requesting blood components from blood banks
Consulting transfusion medicine specialist 18 (52.9)
Specific system for ABOi SOT other than consultation 8 (23.5)
By phone 6 (17.7)
No difference from general transfusion request 2 (5.9)

Abbreviations: ABOi SOT, ABO-incompatible solid organ transplantation; RBC, red blood cell.

Ann Lab Med 2022;42:105~109

© Ann Lab Med